• 2-NBDG Maps Glycolytic Uptake in Glioblastoma

  2026-08-21

  Learn how 2-NBDG can distinguish glucose transport and retention from downstream glycolytic activity in glioblastoma. This mechanistic guide connects fluorescent uptake measurements with recent PXDN–LDHA findings and practical assay design.

• JZL184 in Pain Research: Assay Design

  2026-08-20

  JZL184 is a selective monoacylglycerol lipase inhibitor for dissecting 2-AG biology, CB1 signaling, and pain-related behavior. This guide develops an assay-centered framework that connects endocannabinoid signaling modulation with sensory, affective, biochemical, and circuit-level readouts.

• 20-HETE–TRPV1 Signaling in Chronic Dermatitis

  2026-08-20

  The reference study identifies elevated 20-HETE as a peripheral lipid signal that activates sensitized TRPV1 channels on MrgprA3+ sensory neurons, causing pain-inducing stimuli to produce itch-like scratching in chronic dermatitis. Its combination of sensory-neuron manipulation, electrophysiology, metabolomics, and pharmacological inhibition provides a mechanistic framework for studying allokinesis and potential itch interventions.

• Podophyllotoxin: From Mitotic Arrest to MDR Strategy

  2026-08-19

  A translational analysis of Podophyllotoxin biology, multidrug-resistance research, assay design, formulation strategy, and the boundaries between a mechanistic research reagent and clinical product concepts.

• DGLA–ACSL4 Ferroptosis in AML Cells

  2026-08-19

  The reference study identifies dihomo-γ-linolenic acid (DGLA) as a lipid-metabolic trigger of ferroptosis in acute myeloid leukemia (AML) cells and places ACSL4 at the center of this response. Its combination of targeted metabolomics, fatty-acid testing, ACSL4 knockout, and in vivo dietary intervention provides a mechanistic framework for exploiting ferroptosis in treatment-resistant leukemia.

• ω-Agatoxin IVA TFA: Cav2.1 Workflow Guide

  2026-08-18

  ω-Agatoxin IVA TFA enables selective interrogation of Cav2.1-dependent calcium entry, synaptic release, and seizure-related phenotypes. This practical guide connects nanomolar electrophysiology with structure-aware assay design, epilepsy animal model planning, and troubleshooting.

• Metformin Hydrochloride: AMPK and HO Research

  2026-08-18

  Metformin Hydrochloride, also called Metformin HCl, is a widely studied metabolic regulator that suppresses hepatic gluconeogenesis without directly stimulating insulin secretion. Research models connect its AMPK, mitochondrial redox, lipid-regulatory, and Nr4a1/Wnt/β-catenin effects to glucose homeostasis and experimental heterotopic ossification biology.

• Anisomycin Workflows for JNK and Apoptosis

  2026-08-17

  Anisomycin is a practical JNK agonist for time-resolved apoptosis assays across cancer and stress-response models. This guide combines solvent-aware handling, quantitative signaling workflows, and a cautious neuroscience extension inspired by recent neuroligin 1 research.

• NF 449 for P2X1 Platelet Studies

  2026-08-17

  NF 449 combines strong recombinant P2X1 potency with a practical workflow for separating ATP-driven signaling from broader platelet P2-receptor effects. Use it to refine platelet activation studies, collagen-induced platelet aggregation assays, and translational antithrombotic agent research without treating a single concentration as universally selective.

• MK-5108 (VX-689): AURKA Assay Strategy

  2026-08-16

  MK-5108 (VX-689) is a highly selective Aurora A inhibitor for connecting kinase biochemistry with cell-cycle and retinoblastoma research. This guide explains how AURKA biology, assay design, and xenograft evidence should shape experimental interpretation.

• Nadolol (SQ-11725): PK Workflows for Beta Blockade

  2026-08-15

  Nadolol (SQ-11725) combines reproducible non-selective beta-adrenergic blockade with transporter-aware pharmacokinetic questions. This practical guide shows how to design cardiovascular assays, interpret OATP1A2-related disposition, and adapt disease-state PK lessons without overextending evidence from a MASH model.

• Cy3 RNA Labeling Kit: HyperScribe™ T7

  2026-08-14

  The HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus supports in vitro transcription of randomly Cy3-modified RNA probes for fluorescence-based research workflows. It is intended for applications such as in situ hybridization and Northern blotting, but it is not for diagnostic, therapeutic, or medical use.

• T7 RNA Polymerase for Translational RNA Workflows

  2026-08-14

  T7 RNA Polymerase converts promoter-bearing DNA into research-grade RNA for vaccine design, antisense studies, RNAi, and functional assays. This guide connects template engineering and reaction optimization with the comparative mRNA vaccine findings reported for varicella-zoster virus glycoprotein E.

• Morin Workflows for Mitochondrial and Fluorescent Assays

  2026-08-13

  Morin connects mechanistic studies of oxidative stress, inflammation, and podocyte energy metabolism with a practical fluorescent aluminum-ion assay. This guide translates those properties into reproducible workflows, control strategies, and troubleshooting steps while keeping preclinical findings distinct from clinical conclusions.

• DFO: From Latent Prints to Assay-Smart Fluorescence

  2026-08-13

  DFO (9H-1,8-Diazafluoren-9-one) is a fluorescent reagent for amino-acid-based latent fingerprint detection on porous evidence. This article connects its forensic chemistry with modern assay-design lessons from a zebrafish ferroptosis study while clearly defining the limits of that cross-domain comparison.

16108 records 1/1074 page Next 12345 下5页 Last page